"Xiedi" expands the Evarepamycin coronary artery coating stent - Taiwan Registration 5fee14621e9ca462ca7747b28fadc8e6
Access comprehensive regulatory information for "Xiedi" expands the Evarepamycin coronary artery coating stent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 5fee14621e9ca462ca7747b28fadc8e6 and manufactured by CID S.P.A.. The authorized representative in Taiwan is BUDDY MEDICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free Database
Powered by Pure Global AI
89,000+ Devices
5fee14621e9ca462ca7747b28fadc8e6
Registration Details
Taiwan FDA Registration: 5fee14621e9ca462ca7747b28fadc8e6
Device Details
"Xiedi" expands the Evarepamycin coronary artery coating stent
TW: โๅธ่พ่ฟชโ ๆด็ซๅฎไพ่้ทๅธ้ปด็ด ๅ ็ๅ่ๅก่ฅๆฏๆถ
Risk Class 3

